Viewing nowGaba New Extended-Release Tablet 75mg (Pregabalin)
Pregabalin 42mg
Tablet · Prescription medication
Hanlim Pharmaceutical Co., Ltd.

MFDS item code 202401342 · Approved 2024.05.29 · Insurance code 645307080
Treatment of peripheral neuropathic pain in adults
This medication is used to relieve pain caused by peripheral neuropathy in adults. It helps to reduce pain resulting from nerve damage, thereby improving the quality of life for patients. By alleviating pain, it assists in minimizing discomfort during daily activities and promoting a more comfortable state. Thus, it is effective for the treatment of peripheral neuropathic pain.
Administer once daily after the evening meal. Swallow this medicine whole; do not split, crush, or chew it. As this medicine is primarily excreted by the kidneys, the dose should be adjusted in patients with impaired renal function (see section '2. Patients with renal impairment'). Adults: This medicine may be administered at a starting dose of 1 tablet (150 mg) once daily. Based on the response and tolerability of each patient, the dose may be increased at weekly intervals up to a maximum of 600 mg per day. Discontinuation of treatment: Based on current clinical experience, if treatment with this medicine is discontinued, it should be withdrawn gradually over an interval of at least 1 week. 2. Patients with renal impairment This medicine (pregabalin 75mg) should be used only as the starting dose in patients with moderate renal impairment. Considering dose-dependent adverse reactions and the fact that pregabalin is primarily excreted by the kidneys, adjust the dose in patients with impaired renal function. Dose adjustment in patients with renal impairment is based on creatinine clearance (CLcr) [Table 1]. ≥60 mL/min: Starting dose 150 mg/day, maximum dose 600 mg/day, once daily ≥30-<60 mL/min: Starting dose 75 mg/day, maximum dose 300 mg/day, once daily The safety and efficacy of this medicine have not been established in patients with severe renal impairment or end-stage renal disease with creatinine clearance (CLcr) less than 30 mL/min (see '2) Pharmacokinetic information' under '11. Information for healthcare professionals' in the Precautions for Use section). 3. Patients with hepatic impairment The safety and efficacy of this medicine have not been established in patients with hepatic impairment. 5. Older adults (aged 65 years and older) The safety and efficacy of this medicine have not been established in older adults aged 65 years and older.
4. Pediatric and adolescent patients The safety and efficacy of this medicine have not been established in pediatric and adolescent patients under 19 years of age.
This medication may increase the risk of suicidal thoughts or behaviors, so if mood changes or symptoms of depression occur during treatment, it is important to consult a doctor immediately. Patients with hypersensitivity to this medication should not take it. Diabetic patients may experience weight gain after taking this medication, which may require adjustments to their blood glucose control medications. If allergic reactions such as angioedema occur, the medication should be discontinued immediately, and healthcare professionals should be informed. Elderly patients must be especially careful at the beginning of treatment due to the risk of dizziness or drowsiness that may lead to falls. Transient blurred vision or changes in eyesight may occur; consult a doctor if any unusual symptoms arise. Discontinuation of this medication suddenly may cause withdrawal symptoms such as insomnia, headache, and anxiety, so it should be tapered off gradually according to a doctor's instructions. Due to the risk of drug abuse, patients with a history of substance misuse should use this medication cautiously. Patients with impaired kidney function may require dose adjustments. Patients with cardiovascular diseases should consult a doctor before use. Caution is advised when using this medication with opioid analgesics, as it may increase the central nervous system depressant effects. Patients with respiratory or neurological diseases, and elderly individuals may be at risk of severe respiratory depression and might need dose adjustments. Pregnant women should avoid this medication, especially in early pregnancy, due to the risk of fetal malformations, unless under special circumstances, and women of childbearing age should use effective contraceptive methods. Side effects such as dizziness, drowsiness, weight gain, and constipation may occur during use, so caution is advised. It is advisable to avoid hazardous activities such as driving or operating machinery until symptoms stabilize after taking this medication. Severe skin reactions may rarely occur; if any skin abnormalities arise, the medication should be discontinued immediately and healthcare professionals consulted. This medication has minimal interactions with other drugs; however, caution is advised when used with central nervous system depressants, as it may increase side effects. Breastfeeding women should consult a doctor before using this medication, as it may be transmitted through breast milk, prompting a choice between stopping the medication or breastfeeding. In cases of overdose, symptoms may include confusion, drowsiness, depression, and seizures, requiring immediate emergency treatment. Keep this medication out of reach of children, and be careful not to transfer it into other containers.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is advisable to maintain a storage temperature between 1°C and 30°C at room temperature to preserve its effectiveness.
This medication is a white to pale yellow, oblong, film-coated extended-release tablet.
30 tablets/PTP [6 tablets/PTP X 5]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPregabalin 42mg
Tablet · Prescription medication
Hanlim Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.